Resistance to antimicrobial peptides in Gram-negative bacteria

FEMS Microbiology Letters

Volumn 330, Issue 2, 2012, Pages 81-89

  Gruenheid, Samantha ^a   Le Moual, Hervé ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Antimicrobial peptides; Cathelicidins; Defensins; Gram negative bacteria; Innate immunity

Indexed keywords

ALPHA DEFENSIN; BACTERIAL POLYSACCHARIDE; BETA DEFENSIN; BUTYRIC ACID; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; MATRILYSIN; POLYMYXIN B; POLYPEPTIDE ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL MEMBRANE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; DOWN REGULATION; GENE EXPRESSION REGULATION; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; PYELONEPHRITIS; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SHIGELLOSIS; SHORT SURVEY; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; HUMANS; MAMMALS;

BACTERIA (MICROORGANISMS); FUNGI; MAMMALIA; NEGIBACTERIA;

EID: 84859444332     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2012.02528.x     Document Type: Short Survey

References (78)

1. Aires JR & Nikaido H (2005) Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli. J Bacteriol 187: 1923-1929.
2. Bader MW, Sanowar S, Daley ME, Schneider AR, Cho U, Xu W, Klevit RE, Le Moual H & Miller SI (2005) Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 122: 461-472.
3. Bals R, Weiner DJ, Meegalla RL & Wilson JM (1999) Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J Clin Invest 103: 1113-1117.
4. Banemann A, Deppisch H & Gross R (1998) The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides. Infect Immun 66: 5607-5612.
5. Belas R, Manos J & Suvanasuthi R (2004) Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides. Infect Immun 72: 5159-5167.
6. Bergman P, Johansson L, Asp V, Plant L, Gudmundsson GH, Jonsson AB & Agerberth B (2005) Neisseria gonorrhoeae downregulates expression of the human antimicrobial peptide LL-37. Cell Microbiol 7: 1009-1017.
7. Bijlsma JJ & Groisman EA (2003) Making informed decisions: regulatory interactions between two-component systems. Trends Microbiol 11: 359-366.
8. Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3: 238-250.
9. Campos MA, Vargas MA, Regueiro V, Llompart CM, Alberti S & Bengoechea JA (2004) Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun 72: 7107-7114.
10. Chakraborty K, Ghosh S, Koley H et al. (2008) Bacterial exotoxins downregulate cathelicidin (hCAP-18/LL-37) and human beta-defensin 1 (HBD-1) expression in the intestinal epithelial cells. Cell Microbiol 10: 2520-2537.
11. Chromek M, Slamova Z, Bergman P et al. (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12: 636-641.
12. Darveau RP, Blake J, Seachord CL, Cosand WL, Cunningham MD, Cassiano-Clough L & Maloney G (1992) Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity. J Clin Invest 90: 447-455.
13. Davidson AL, Dassa E, Orelle C & Chen J (2008) Structure, function, and evolution of bacterial ATP-binding cassette systems. Microbiol Mol Biol Rev 72: 317-364.
14. Eisenhauer PB, Harwig SS & Lehrer RI (1992) Cryptdins: antimicrobial defensins of the murine small intestine. Infect Immun 60: 3556-3565.
15. Eswarappa SM, Panguluri KK, Hensel M & Chakravortty D (2008) The yejABEF operon of Salmonella confers resistance to antimicrobial peptides and contributes to its virulence. Microbiology 154: 666-678.
16. Farris C, Sanowar S, Bader MW, Pfuetzner R & Miller SI (2010) Antimicrobial peptides activate the Rcs regulon through the outer membrane lipoprotein RcsF. J Bacteriol 192: 4894-4903.
17. Fernandez L, Gooderham WJ, Bains M, McPhee JB, Wiegand I & Hancock RE (2010) Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob Agents Chemother 54: 3372-3382.
18. Foschiatti M, Cescutti P, Tossi A & Rizzo R (2009) Inhibition of cathelicidin activity by bacterial exopolysaccharides. Mol Microbiol 72: 1137-1146.
19. Galvan EM, Lasaro MA & Schifferli DM (2008) Capsular antigen fraction 1 and Pla modulate the susceptibility of Yersinia pestis to pulmonary antimicrobial peptides such as cathelicidin. Infect Immun 76: 1456-1464.
20. Ganz T, Metcalf JA, Gallin JI, Boxer LA & Lehrer RI (1988) Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J Clin Invest 82: 552-556.
21. Groisman EA, Parra-Lopez C, Salcedo M, Lipps CJ & Heffron F (1992) Resistance to host antimicrobial peptides is necessary for Salmonella virulence. P Natl Acad Sci USA 89: 11939-11943.
22. Guina T, Yi EC, Wang H, Hackett M & Miller SI (2000) A PhoP-regulated outer membrane protease of Salmonella enterica serovar Typhimurium promotes resistance to alpha-helical antimicrobial peptides. J Bacteriol 182: 4077-4086.
23. Gunn JS (2008) The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more. Trends Microbiol 16: 284-290.
24. Guo L, Lim KB, Poduje CM, Daniel M, Gunn JS, Hackett M & Miller SI (1998) Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 95: 189-198.
25. Gutner M, Chaushu S, Balter D & Bachrach G (2009) Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis. Infect Immun 77: 5558-5563.
26. Haiko J, Suomalainen M, Ojala T, Lahteenmaki K & Korhonen TK (2009) Breaking barriers-attack on innate immune defences by omptin surface proteases of enterobacterial pathogens. Innate Immun 15: 67-80.
27. Hancock RE & Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24: 1551-1557.
28. Herasimenka Y, Benincasa M, Mattiuzzo M, Cescutti P, Gennaro R & Rizzo R (2005) Interaction of antimicrobial peptides with bacterial polysaccharides from lung pathogens. Peptides 26: 1127-1132.
29. Hritonenko V & Stathopoulos C (2007) Omptin proteins: an expanding family of outer membrane proteases in Gram-negative Enterobacteriaceae. Mol Membr Biol 24: 395-406.
30. Iimura M, Gallo RL, Hase K, Miyamoto Y, Eckmann L & Kagnoff MF (2005) Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol 174: 4901-4907.
31. Ilg K, Endt K, Misselwitz B, Stecher B, Aebi M & Hardt WD (2009) O-antigen-negative Salmonella enterica serovar Typhimurium is attenuated in intestinal colonization but elicits colitis in streptomycin-treated mice. Infect Immun 77: 2568-2575.
32. Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, Agerberth B & Gudmundsson G (2001) Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 7: 180-185.
33. Jia W, El Zoeiby A, Petruzziello TN, Jayabalasingham B, Seyedirashti S & Bishop RE (2004) Lipid trafficking controls endotoxin acylation in outer membranes of Escherichia coli. J Biol Chem 279: 44966-44975.
34. Jones A, Georg M, Maudsdotter L & Jonsson AB (2009) Endotoxin, capsule, and bacterial attachment contribute to Neisseria meningitidis resistance to the human antimicrobial peptide LL-37. J Bacteriol 191: 3861-3868.
35. Kai-Larsen Y, Luthje P, Chromek M et al. (2010) Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog 6: e1001010.
36. Kooi C & Sokol PA (2009) Burkholderia cenocepacia zinc metalloproteases influence resistance to antimicrobial peptides. Microbiology 155: 2818-2825.
37. Koprivnjak T & Peschel A (2011) Bacterial resistance mechanisms against host defense peptides. Cell Mol Life Sci 68: 2243-2254.
38. Kumarasamy KK, Toleman MA, Walsh TR et al. (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10: 597-602.
39. Le Sage V, Zhu L, Lepage C, Portt A, Viau C, Daigle F, Gruenheid S & Le Moual H (2009) An outer membrane protease of the omptin family prevents activation of the Citrobacter rodentium PhoPQ two-component system by antimicrobial peptides. Mol Microbiol 74: 98-111.
40. Lewis LA, Choudhury B, Balthazar JT, Martin LE, Ram S, Rice PA, Stephens DS, Carlson R & Shafer WM (2009) Phosphoethanolamine substitution of lipid A and resistance of Neisseria gonorrhoeae to cationic antimicrobial peptides and complement-mediated killing by normal human serum. Infect Immun 77: 1112-1120.
41. Llobet E, Tomas JM & Bengoechea JA (2008) Capsule polysaccharide is a bacterial decoy for antimicrobial peptides. Microbiology 154: 3877-3886.
42. Lopez-Solanilla E, Garcia-Olmedo F & Rodriguez-Palenzuela P (1998) Inactivation of the sapA to sapF locus of Erwinia chrysanthemi reveals common features in plant and animal bacterial pathogenesis. Plant Cell 10: 917-924.
43. Loutet SA & Valvano MA (2011) Extreme antimicrobial peptide and polymyxin B resistance in the genus Burkholderia. Frontiers Microbiol 2: 159.
44. Loutet SA, Flannagan RS, Kooi C, Sokol PA & Valvano MA (2006) A complete lipopolysaccharide inner core oligosaccharide is required for resistance of Burkholderia cenocepacia to antimicrobial peptides and bacterial survival in vivo. J Bacteriol 188: 2073-2080.
45. Lupp C, Hancock RE & Ruby EG (2002) The Vibrio fischeri sapABCDF locus is required for normal growth, both in culture and in symbiosis. Arch Microbiol 179: 57-65.
46. Maisetta G, Brancatisano FL, Esin S, Campa M & Batoni G (2011) Gingipains produced by Porphyromonas gingivalis ATCC49417 degrade human-beta-defensin 3 and affect peptide's antibacterial activity in vitro. Peptides 32: 1073-1077.
47. Mason KM, Munson RS Jr & Bakaletz LO (2005) A mutation in the sap operon attenuates survival of nontypeable Haemophilus influenzae in a chinchilla model of otitis media. Infect Immun 73: 599-608.
48. Mason KM, Raffel FK, Ray WC & Bakaletz LO (2011) Heme utilization by nontypeable Haemophilus influenzae is essential and dependent on Sap transporter function. J Bacteriol 193: 2527-2535.
49. Miller SI, Ernst RK & Bader MW (2005) LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 3: 36-46.
50. Mount KL, Townsend CA, Rinker SD et al. (2010) Haemophilus ducreyi SapA contributes to cathelicidin resistance and virulence in humans. Infect Immun 78: 1176-1184.
51. Nagy G, Danino V, Dobrindt U, Pallen M, Chaudhuri R, Emody L, Hinton JC & Hacker J (2006) Down-regulation of key virulence factors makes the Salmonella enterica serovar Typhimurium rfaH mutant a promising live-attenuated vaccine candidate. Infect Immun 74: 5914-5925.
52. Nizet V (2006) Antimicrobial peptide resistance mechanisms of human bacterial pathogens. Curr Issues Mol Biol 8: 11-26.
53. Novikova M, Metlitskaya A, Datsenko K, Kazakov T, Kazakov A, Wanner B & Severinov K (2007) The Escherichia coli Yej transporter is required for the uptake of translation inhibitor microcin C. J Bacteriol 189: 8361-8365.
54. Padilla E, Llobet E, Domenech-Sanchez A, Martinez-Martinez L, Bengoechea JA & Alberti S (2010) Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. Antimicrob Agents Chemother 54: 177-183.
55. Parra-Lopez C, Baer MT & Groisman EA (1993) Molecular genetic analysis of a locus required for resistance to antimicrobial peptides in Salmonella typhimurium. EMBO J 12: 4053-4062.
56. Prost LR, Daley ME, Bader MW, Klevit RE & Miller SI (2008) The PhoQ histidine kinases of Salmonella and Pseudomonas spp. are structurally and functionally different: evidence that pH and antimicrobial peptide sensing contribute to mammalian pathogenesis. Mol Microbiol 69: 503-519.
57. Putsep K, Carlsson G, Boman HG & Andersson M (2002) Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360: 1144-1149.
58. Raqib R, Sarker P, Bergman P et al. (2006) Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. P Natl Acad Sci USA 103: 9178-9183.
59. Richards SM, Strandberg KL & Gunn JS (2010) Salmonella-regulated lipopolysaccharide modifications. Subcell Biochem 53: 101-122.
60. Rieg S, Huth A, Kalbacher H & Kern WV (2009) Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps. Int J Antimicrob Agents 33: 174-176.
61. Rinker SD, Trombley MP, Gu X, Fortney KR & Bauer ME (2011) Deletion of mtrC in Haemophilus ducreyi increases sensitivity to human antimicrobial peptides and activates the CpxRA regulon. Infect Immun 79: 2324-2334.
62. Rosenberger CM, Gallo RL & Finlay BB (2004) Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. P Natl Acad Sci USA 101: 2422-2427.
63. Salzman NH, Ghosh D, Huttner KM, Paterson Y & Bevins CL (2003a) Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422: 522-526.
64. Salzman NH, Chou MM, de Jong H, Liu L, Porter EM & Paterson Y (2003b) Enteric salmonella infection inhibits Paneth cell antimicrobial peptide expression. Infect Immun 71: 1109-1115.
65. Salzman NH, Hung K, Haribhai D et al. (2010) Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 11: 76-83.
66. Schmidtchen A, Frick IM, Andersson E, Tapper H & Bjorck L (2002) Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol 46: 157-168.
67. Shafer WM, Qu X, Waring AJ & Lehrer RI (1998) Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. P Natl Acad Sci USA 95: 1829-1833.
68. Shelton CL, Raffel FK, Beatty WL, Johnson SM & Mason KM (2011) Sap transporter mediated import and subsequent degradation of antimicrobial peptides in Haemophilus. PLoS Pathog 7: e1002360.
69. Sherman MP, Bennett SH, Hwang FF, Sherman J & Bevins CL (2005) Paneth cells and antibacterial host defense in neonatal small intestine. Infect Immun 73: 6143-6146.
70. Sperandio B, Regnault B, Guo J, Zhang Z, Stanley SL Jr, Sansonetti PJ & Pedron T (2008) Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression. J Exp Med 205: 1121-1132.
71. Spinosa MR, Progida C, Tala A, Cogli L, Alifano P & Bucci C (2007) The Neisseria meningitidis capsule is important for intracellular survival in human cells. Infect Immun 75: 3594-3603.
72. Stumpe S, Schmid R, Stephens DL, Georgiou G & Bakker EP (1998) Identification of OmpT as the protease that hydrolyzes the antimicrobial peptide protamine before it enters growing cells of Escherichia coli. J Bacteriol 180: 4002-4006.
73. Sutherland I (2001) Biofilm exopolysaccharides: a strong and sticky framework. Microbiology 147: 3-9.
74. Thomassin J, Brannon J, Gibbs BF, Gruenheid S & Le Moual H (2012) OmpT outer membrane proteases of enterohemorrhagic and enteropathogenic Escherichia coli contribute differently to the degradation of human LL-37. Infect Immun 80: 483-492.
75. Tzeng YL, Ambrose KD, Zughaier S, Zhou X, Miller YK, Shafer WM & Stephens DS (2005) Cationic antimicrobial peptide resistance in Neisseria meningitidis. J Bacteriol 187: 5387-5396.
76. Wang X, Ribeiro AA, Guan Z, Abraham SN & Raetz CR (2007) Attenuated virulence of a Francisella mutant lacking the lipid A 4'-phosphatase. P Natl Acad Sci USA 104: 4136-4141.
77. Wilson CL, Ouellette AJ, Satchell DP, Ayabe T, Lopez-Boado YS, Stratman JL, Hultgren SJ, Matrisian LM & Parks WC (1999) Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286: 113-117.
78. Yeung AT, Gellatly SL & Hancock RE (2011) Multifunctional cationic host defence peptides and their clinical applications. Cell Mol Life Sci 68: 2161-2176.